Hydrocortisone: Difference between revisions
| (5 intermediate revisions by the same user not shown) | |||
| Line 14: | Line 14: | ||
[[File:Hydrocortisone 20mg.mp3]] | [[File:Hydrocortisone 20mg.mp3]] | ||
'''Equivalent anti-inflammatory doses of steroids | '''Equivalent anti-inflammatory doses of steroids | ||
{| class = "wikitable" | {| class = "wikitable" | ||
| Line 31: | Line 30: | ||
| | | | ||
| triamcinolone 4 mg | | triamcinolone 4 mg | ||
|} | |} | ||
==Drug Names== | |||
== | |||
{| class="wikitable" | {| class="wikitable" | ||
!Generic Name 藥名 | !Generic Name 藥名 | ||
| Line 50: | Line 42: | ||
|P1S1S3 | |P1S1S3 | ||
|} | |} | ||
==Mechanism of Action== | |||
Immunosuppression agent, | |||
Steroid replacement agent, | |||
Anti-inflammatory agent | |||
==Dosage== | ==Dosage== | ||
| Line 55: | Line 52: | ||
Hydrocortisone is used, usually with a more potent mineralocorticoid fludrocortisone, for replacement therapy in adrenocortical insufficiency. | Hydrocortisone is used, usually with a more potent mineralocorticoid fludrocortisone, for replacement therapy in adrenocortical insufficiency. | ||
{| class="wikitable" | |||
!style="text-align: left"| By Oral | |||
|as replacement therapy, 20-30 mg daily (usually in 2 doses, the larger in the morning and the smaller in the early evening, to mimic the circadian rhythm of the body). | |||
|- | |||
!style="text-align: left"| By intramuscular injection or slow intravenous injection | |||
|100-500 mg, 3-4 times in 24 hours or as required. | |||
|} | |||
{| class="wikitable" | |||
!style="text-align: left"| Child dose: as replacement therapy in adrenocortical insufficiency | |||
|- | |||
!style="text-align: left"| By slow intravenous injection | |||
|- | |||
|style="text-align: left"| Up to 1 year: 25 mg | |||
|- | |||
|style="text-align: left"| 1-5 years: 50 mg | |||
|- | |||
|style="text-align: left"| 6-12 years: 100 mg | |||
|} | |||
==Side Effects== | ==Side Effects== | ||
Short-term use include nausea and feeling tired. More severe side effects include psychiatric problems including euphoria, nightmares, insomnia, irritability, confusion, suicidal thoughts and behavioral disturbances. This may occur in about 5% of people. | ===Short-term use=== | ||
include nausea and feeling tired. More severe side effects include psychiatric problems including euphoria, nightmares, insomnia, irritability, confusion, suicidal thoughts and behavioral disturbances. This may occur in about 5% of people. | |||
Long-term steroid use can lead to | ===Long-term steroid use can lead to=== | ||
{| class = "wikitable" | {| class = "wikitable" | ||
| Line 75: | Line 83: | ||
| | | | ||
|- | |- | ||
!|Steroid-induced diabetes | !style="text-align: left"| Steroid-induced diabetes | ||
| | | | ||
|- | |- | ||
!|Osteoporosis, muscle wasting and weakness | !style="text-align: left"| Osteoporosis, muscle wasting and weakness | ||
|which is a danger, particularly in the elderly, as it can result in osteoporotic fractures for example of the hip or vertebrae | |which is a danger, particularly in the elderly, as it can result in osteoporotic fractures for example of the hip or vertebrae | ||
|- | |- | ||
| Line 90: | Line 98: | ||
|menstrual irregularities and amenorrhea, hirsutism, weight gain, hyperlipidemia | |menstrual irregularities and amenorrhea, hirsutism, weight gain, hyperlipidemia | ||
|- | |- | ||
!Neuropsychiatric side effects | !style="text-align: left"| Neuropsychiatric side effects | ||
|aggravation of schizophrenia, aggravation of epilepsy, insomnia, irritability, mood changes | |aggravation of schizophrenia, aggravation of epilepsy, insomnia, irritability, mood changes | ||
|- | |- | ||
!Dermatological effects | !style="text-align: left"| Dermatological effects | ||
|easy bruising, impaired wound healing, and thinning of skin | |easy bruising, impaired wound healing, and thinning of skin | ||
|- | |- | ||
!Ophthalmic effects | !style="text-align: left"| Ophthalmic effects | ||
|glaucoma, corneal or scleral thinning and exacerbation of ophthalmic viral or fungal disease | |glaucoma, corneal or scleral thinning and exacerbation of ophthalmic viral or fungal disease | ||
|} | |||
Side-effects can be minimized by using lowest effective dose for minimum period possible. | Side-effects can be minimized by using lowest effective dose for minimum period possible. | ||
==Pharmacokinetics== | ==Pharmacokinetics== | ||
| Line 114: | Line 121: | ||
Hydrocortisone crosses the placenta and may distributed in small amounts into breast milk. | Hydrocortisone crosses the placenta and may distributed in small amounts into breast milk. | ||
==Drug Management== | ==Drug Management== | ||
===Monitoring=== | |||
*Elderly (close supervision required particularly on long-term treatment) | *Elderly (close supervision required particularly on long-term treatment) | ||
*Frequent monitoring required if history of tuberculosis (or X-ray changes) | *Frequent monitoring required if history of tuberculosis (or X-ray changes) | ||
| Line 127: | Line 133: | ||
*Height should be monitored in children receiving prolonged therapy with inhaled or nasal steroid. | *Height should be monitored in children receiving prolonged therapy with inhaled or nasal steroid. | ||
===Drug interaction=== | |||
Interactions do not generally apply to steroid used for topical action including inhalation, unless specified. | Interactions do not generally apply to steroid used for topical action including inhalation, unless specified. | ||
{| class = "wikitable" | {| class = "wikitable" | ||
!style="text-align: left"| Drugs given with steroid | !style="text-align: left"| Drugs given with steroid | ||
!Potential adverse drug interactions | !style="text-align: left"| Potential adverse drug interactions | ||
|- | |- | ||
|NSAIDs | |NSAIDs | ||
| Line 179: | Line 185: | ||
|} | |} | ||
===Caution=== | |||
*Children and adolescents (growth restriction possibly irreversible) | *Children and adolescents (growth restriction possibly irreversible) | ||
*Osteoporosis (post-menopausal women at special risk) | *Osteoporosis (post-menopausal women at special risk) | ||
| Line 194: | Line 200: | ||
*Myasthenia gravis | *Myasthenia gravis | ||
===Contraindication=== | |||
*acute infections | *acute infections | ||
*patients with active or doubtfully quiescent tuberculosis | *patients with active or doubtfully quiescent tuberculosis | ||
*concurrent treatment live virus vaccines for at least 3 months afterwards | *concurrent treatment live virus vaccines for at least 3 months afterwards | ||
===Hepatic impairment=== | |||
When steroids are administered orally or parenterally, the plasma-drug concentration may be increased in patients with hepatic impairment. The patient should be monitored closely. | When steroids are administered orally or parenterally, the plasma-drug concentration may be increased in patients with hepatic impairment. The patient should be monitored closely. | ||
===Renal impairment=== | |||
Should be used with caution in patients with renal impairment. | Should be used with caution in patients with renal impairment. | ||
===Pregnancy=== | |||
Hydrocortisone should only be used in pregnant women when benefits outweigh the risks. | Hydrocortisone should only be used in pregnant women when benefits outweigh the risks. | ||
*No convincing evidence that systemic steroids increase the incidence of congenital abnormalities such as cleft palate or lip. | *No convincing evidence that systemic steroids increase the incidence of congenital abnormalities such as cleft palate or lip. | ||
| Line 214: | Line 220: | ||
{| class = "wikitable" | {| class = "wikitable" | ||
!style="text-align: left"| Prolonged use of steroid | !style="text-align: left"| Prolonged use of steroid | ||
! | !style="text-align: left"| Advice to patient | ||
|- | |- | ||
| | |style="text-align: left"| Immunosuppression | ||
Prolonged use can increase susceptibility to infection | Prolonged use can increase susceptibility to infection | ||
|Avoid contact with people who have chickenpox, shingles, or measles. | |Avoid contact with people who have chickenpox, shingles, or measles. | ||
|- | |- | ||
| | | | ||
Adrenal suppression | |||
Steroid suppresses the endogenous secretion of corticotropin by the anterior pituitary, resulting the adrenal cortex becomes atrophied. | Steroid suppresses the endogenous secretion of corticotropin by the anterior pituitary, resulting the adrenal cortex becomes atrophied. | ||
If given for more than 3 weeks, treatment must not be stopped gradually. | If given for more than 3 weeks, treatment must not be stopped gradually. | ||
Latest revision as of 23:05, 13 October 2020
Hydrocortisone (中文: 氫化可的松) is a steroid with anti-inflammatory and immunosuppressant effects. Indications include:
- Hypersensitivity reactions e.g. anaphylaxis and angioedema
- Asthma
- Inflammatory bowel disease
- Eczema, psoriasis and other inflammatory skin conditions
- Rheumatoid arthritis
- Treatment of choice for adrenocortical insufficiency
Hydrocortisone can be given by mouth, topically, or by injection.
Pronunciation[edit]
Hydrocortisone 20mg[edit]
Equivalent anti-inflammatory doses of steroids
| Prednisolone 5 mg is equivalent to | Betamethasone 750 micrograms |
|---|---|
| dexamethasone 750 micrograms | |
| hydrocortisone 20 mg | |
| methylprednisolone 4 mg | |
| triamcinolone 4 mg |
Drug Names[edit]
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Hydrocortisone Tablet 20mg | HYDR06 | P1S1S3 |
Mechanism of Action[edit]
Immunosuppression agent, Steroid replacement agent, Anti-inflammatory agent
Dosage[edit]
Hydrocortisone is used, usually with a more potent mineralocorticoid fludrocortisone, for replacement therapy in adrenocortical insufficiency.
| By Oral | as replacement therapy, 20-30 mg daily (usually in 2 doses, the larger in the morning and the smaller in the early evening, to mimic the circadian rhythm of the body). |
|---|---|
| By intramuscular injection or slow intravenous injection | 100-500 mg, 3-4 times in 24 hours or as required. |
| Child dose: as replacement therapy in adrenocortical insufficiency |
|---|
| By slow intravenous injection |
| Up to 1 year: 25 mg |
| 1-5 years: 50 mg |
| 6-12 years: 100 mg |
Side Effects[edit]
Short-term use[edit]
include nausea and feeling tired. More severe side effects include psychiatric problems including euphoria, nightmares, insomnia, irritability, confusion, suicidal thoughts and behavioral disturbances. This may occur in about 5% of people.
Long-term steroid use can lead to[edit]
| Adrenal suppression | |
|---|---|
| Steroid-induced diabetes | |
| Osteoporosis, muscle wasting and weakness | which is a danger, particularly in the elderly, as it can result in osteoporotic fractures for example of the hip or vertebrae |
| Susceptibility to infection | |
| Cushing’s syndrome | moon face, striae, and acne |
| Endocrine side effects | menstrual irregularities and amenorrhea, hirsutism, weight gain, hyperlipidemia |
| Neuropsychiatric side effects | aggravation of schizophrenia, aggravation of epilepsy, insomnia, irritability, mood changes |
| Dermatological effects | easy bruising, impaired wound healing, and thinning of skin |
| Ophthalmic effects | glaucoma, corneal or scleral thinning and exacerbation of ophthalmic viral or fungal disease |
Side-effects can be minimized by using lowest effective dose for minimum period possible.
Pharmacokinetics[edit]
Hydrocortisone is readily absorbed from the gastrointestinal tract. Peak blood concentrations occur in about an hour. The plasma half-life is about 100 minutes.
It is more than 90% bound to plasma proteins.
Following intramuscular injection, the absorption of the water-soluble sodium phosphate and sodium succinate esters is rapid. Absorption of hydrocortisone acetate after intra-articular or soft-tissue injection is slower. Hydrocortisone is absorbed through the skin.
Hydrocortisone is metabolized in the liver and is excreted in the urine.
Hydrocortisone crosses the placenta and may distributed in small amounts into breast milk.
Drug Management[edit]
Monitoring[edit]
- Elderly (close supervision required particularly on long-term treatment)
- Frequent monitoring required if history of tuberculosis (or X-ray changes)
- Blood sugar level, blood pressure, mood change,
- Monitoring of the fluid intake and output, and daily weight records may give early warning of fluid retention.
- Sodium intake may need to be reduced and calcium and potassium supplements may be necessary.
- Back pain may signify osteoporosis
- Height should be monitored in children receiving prolonged therapy with inhaled or nasal steroid.
Drug interaction[edit]
Interactions do not generally apply to steroid used for topical action including inhalation, unless specified.
| Drugs given with steroid | Potential adverse drug interactions |
|---|---|
| NSAIDs | Increased risk of gastro-intestinal bleeding |
| Rifampicin | Accelerate metabolism of steroid so reduce the effects of steroid |
| Antidiabetics | Steroid antagonize hypoglycaemic effect. Requirements of antidiabetics may be increased. |
Antiepileptics:
|
Accelerate metabolism of steroid so reduce the effects of steroidd |
Antifungals:
|
Increased risk of hypokalaemia |
Antivirals:
|
Increase plasma concentration of steroid – increased risk of adrenal suppression
|
| Digoxin | Increased risk of hypokalaemia |
Diuretics:
|
antagonize diuretic effect, increased risk of hypokalaemia |
| Oral contraceptive (oestrogens) | Increase plasma concentration of steroid |
| Theophylline | Increased risk of hypokalaemia |
Caution[edit]
- Children and adolescents (growth restriction possibly irreversible)
- Osteoporosis (post-menopausal women at special risk)
- Recent myocardial infarction, congestive heart failure
- Glaucoma (including family history)
- Ocular herpes simplex – risk of corneal perforation
- Psychiatric disorders (particularly if history of steroid-induced psychosis)
- Epilepsy
- Peptic ulcer
- Hypothyroidism
- Ulcerative colitis
- Diverticulitis
- Thromboembolic disorders
- Myasthenia gravis
Contraindication[edit]
- acute infections
- patients with active or doubtfully quiescent tuberculosis
- concurrent treatment live virus vaccines for at least 3 months afterwards
Hepatic impairment[edit]
When steroids are administered orally or parenterally, the plasma-drug concentration may be increased in patients with hepatic impairment. The patient should be monitored closely.
Renal impairment[edit]
Should be used with caution in patients with renal impairment.
Pregnancy[edit]
Hydrocortisone should only be used in pregnant women when benefits outweigh the risks.
- No convincing evidence that systemic steroids increase the incidence of congenital abnormalities such as cleft palate or lip.
- Prolonged use increases the risk of intra-uterine growth; but no evidence of intra-uterine growth restriction following short-term treatment.
Note
| Prolonged use of steroid | Advice to patient |
|---|---|
| Immunosuppression
Prolonged use can increase susceptibility to infection |
Avoid contact with people who have chickenpox, shingles, or measles. |
|
Adrenal suppression Steroid suppresses the endogenous secretion of corticotropin by the anterior pituitary, resulting the adrenal cortex becomes atrophied. If given for more than 3 weeks, treatment must not be stopped gradually. |
Patient must mention the course of steroid when receiving treatment for intercurrent illnesses or trauma such as surgery. |
FAQ[edit]
How should I take the tablet?[edit]
Follow all directions on your prescription label. Use prednisolone exactly as directed on the label. Steroids are associated with a risk of GI irritation. The tablet MUST be with or after food to help reduce side-effects.
What should I avoid while taking?[edit]
Avoid abruptly discontinue the medication. Should not be taken with NSAIDs.
What happen if I overdose?[edit]
Contact your primary care doctor. If emergency situation, call 999
What happen if I miss a dose?[edit]
Take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up.
